AI assistant
Medtronic plc — Director's Dealing 2019
Nov 8, 2019
29841_dirs_2019-11-07_3b14b9d5-a91b-4731-923a-099660c8749d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-11-01
Reporting Person: Wall Brett A. (EVP & Group Pres Restora Thera)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 13075 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $106.22 | 2029-10-28 | Ordinary Shares (22579) | Direct | |
| Stock Option (Right to Buy) | $78.00 | 2025-08-03 | Ordinary Shares (11154) | Direct | |
| Stock Option (Right to Buy) | $78.00 | 2025-08-03 | Ordinary Shares (1283) | Direct | |
| Stock Option (Right to Buy) | $88.06 | 2026-08-01 | Ordinary Shares (11356) | Direct | |
| Stock Option (Right to Buy) | $88.06 | 2026-08-01 | Ordinary Shares (1136) | Direct | |
| Stock Option (Right to Buy) | $83.97 | 2027-07-31 | Ordinary Shares (11910) | Direct | |
| Stock Option (Right to Buy) | $83.97 | 2027-07-31 | Ordinary Shares (1191) | Direct | |
| Stock Option (Right to Buy) | $89.08 | 2028-07-30 | Ordinary Shares (16946) | Direct | |
| Stock Option (Right to Buy) | $89.08 | 2028-07-30 | Ordinary Shares (1695) | Direct | |
| Stock Option (Right to Buy) | $103.26 | 2029-07-29 | Ordinary Shares (24223) | Direct | |
| Stock Option (Right to Buy) | $103.26 | 2029-07-29 | Ordinary Shares (1615) | Direct | |
| Stock Option (Right to Buy) | $47.00 | 2023-12-01 | Ordinary Shares (12300) | Direct | |
| Stock Option (Right to Buy) | $74.84 | 2025-01-27 | Ordinary Shares (8018) | Direct |
Footnotes
F1: Includes grants of restricted stock units which vest on the listed date and for the listed number of shares if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth measured over the three most recently completed fiscal years exceeds a 3% cumulative compound annual growth rate (as determined by the Compensation Committee): (i) 3,129 restricted stock units that vest on 7/31/2020; (ii) 2,884 restricted stock units that vest on 7/30/2021; and (iii) 7,062 restricted stock units that vest on 7/29/2022.
F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F3: This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.